Faria Farhat, MD

Current HIV/AIDS Research Activities:

• Site Co-Investigator for following trails sponsored by NIH: 
  • ACTG 5257: A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers
  • A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females. A5240.

• Co-Investigator - A phase II study to assess the safety and immunogenicity of an inactivated swine origin H1N1 Influenza vaccine in HIV-1 infected pregnant women. P 1086.
• Co-Investigator - The Optimized Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen. (ACTG 5241) August 2008 - Present. Sponsored by NIH.
• Co-Investigator - Preservation and expansion of T-cell subsets following HAART de intensification to Atazanavir/ritonavir in adolescents and young adults with CD4 + T cells >350 cells/mm3 initiating HAART. ATN – 061.
• Co-Investigator - Neurocognitive assessment in youth initiating HAART. ATN - 071.

Current HIV/AIDS Educational Activities:

• Teaching Attending for Howard University Hospital's Medical Residents and Fellows
• Lecturer, Medical Students, Howard University College of Medicine

Current HIV/AIDS Clinical Activities:

• Clinical Faculty, Inpatient Infectious Disease Service, Howard University Hospital
• Attending Physician, Center for Infectious Disease Management and Research, Howard University Hospital

Current HIV/AIDS Service Activities:

• Interim Chair, Infection Control, Howard University Hospital
• Interim Chair, Antibiotic Subcommittee, Howard University Hospital